Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.
Thanks!

Click here for a guide on disabling your adblocker.

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

US (CA): 1933 Industries begins cannabis cultivation and CBD manufacturing operations in California

1933 Industries has readied its California operations to begin manufacturing its line of proprietary CBD wellness products with full-spectrum CBD for the California dispensary market, as well as debuting its Alternative Medicine Association (AMA)-branded THC products for the first time in that state.

"Following the execution of a management agreement with California-based, licensed cultivator Green Spectrum, the Company has established both cultivation and extraction capabilities for its AMA-branded products outside of Nevada, as well as for luxury brand Blonde Cannabis, a licensed partner," the team with the company explains. "Local manufacturing of the Canna Hemp line allows the Company to produce full-spectrum CBD infused products for direct distribution to local dispensaries and grants the Company greater flexibility to react to California's changing regulatory environment."

According to cannabinoid market intelligence and consumer research BDS Analytics and Arcview Market Research, the California cannabis industry is on track to post a record $3.1 billion in licensed cannabis sales for 2019, and is projected to grow at a 19% compound annual growth rate (CAGR) to $7.2 billion in 2024, 40% larger than Canada and 253% larger than the next-largest state market in Colorado. Since approving cannabis for recreational use in November 2016, sales in California in 2018 represented about 24% or $2.5 billion of legal cannabis sales in the United States, while the combined sales in Colorado, Washington and Oregon represented approximately 30% of U.S. sales.

"California represents a growth opportunity for 1933 Industries and for our brand partners. The Golden State is a trendsetter when it comes to cannabis brands and we are positioning ourselves to gain market share by working with our local cultivation partners and by bringing our manufacturing expertise to this competitive market," remarked 1933 Industries CEO, Mr. Chris Rebentisch. He continued, "We are developing strategies to compete for market share across the state. We will be offering a diversified portfolio of THC products, encompassing flower and concentrates for both the AMA and Blonde brands, as well as California-compliant CBD products. We have secured a distribution license and we will be expanding our distribution networks for our suite of products, for our licensed partners and for any company that seeks white labelling and distribution into the California market".

Chris Rebentisch, 1933 Industries CEO

With a cultivation area of approximately 10,000 sq. ft. and with an additional 10,000 sq. ft. of shared manufacturing and distribution space in the Los Angeles area, the California facility will serve as the Company's main distribution hub for deliveries across the state. "After a successful trial run of 30,000 units now completed, full spectrum CBD Canna Hemp products will be available at dispensaries later this month, once the products undergo required laboratory testing," they further explain. "Product offerings will include Canna Hemp relief creams, elixirs, lotions, capsules, vape pens and cartridges as well as Canna Hemp X recovery creams and elixirs. The Company anticipates its first harvest from the California facility during the first week of February with a second harvest the following week. The Company expects monthly harvests to yield approximately 100 lbs. of craft-grown flower or its Blonde and AMA brands as well as concentrates."

"Diversification of products and formats helps mitigate the risk of consumer and market changes. We are already a significant player in the cannabis wellness marketplace with our extensive suite of products and our growing list of key partners," said Mr. Rebentisch. "We know that in this industry, quality will prevail and every ingredient that goes into making our products is highly scrutinized for product efficiency, effect and overall consumer experience. Our standards go far beyond what is expected in the industry and being strategically positioned in high growth states such  as Nevada, California and Colorado allows us to execute our growth strategy quickly and efficiently. The opportunity to be a one-stop shop for dispensaries with our 100+ SKUs in a variety of product formats to meet the needs for every consumer is exciting, as it gives us the opportunity to take a lead in this market."

For more information:
1933 Industries
105, 45655 Tamihi Way
Chilliwack, B.C.,
Canada V2R 2M3
604 674 4756
info@1933industries.com    
1933industries.com      

Publication date: